Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-001409
Filing Date
2024-02-26
Accepted
2024-02-26 16:32:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4078
  Complete submission text file 0001950047-24-001409.txt   5552
Mailing Address C/O EXELIXIS INC 170 HARBOR WAY SAN FRANCISCO CA 94083
Business Address
SCANGOS GEORGE A (Reporting) CIK: 0001202102 (see all company filings)

Type: 144

Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Subject) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39083 | Film No.: 24679448
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)